BRCA2 and cancer: According to the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium, 2021, the prevalence of pathogenic variants of BRCA among women with BC was estimated to be 1·3% (associated with BRCA2) and 0·8% (associated with BRCA1) (10).